1Block G,Port FK.Calcium phosphate metabolism and cardiovascular dis-ease in patients with chronic kidney disease.Semin Dial,2003,16:140-147.
2Kanbay M,Goldsmith D,Uyar ME,et al.Magnesium in chronic kidney disease:challenges and opportunities.J Biol Chem,2010,276:280-292.
3Vattikuti R,Towler DA.Osteogenic regulation of vascular calcification:an early perspective.Am J Physiol Endocrinol Metab,2004,286:E686-E696.
4London GM,Guerin AP,Marchais SJ,et al.Arterial media calcification in end-stage renal disease:Impact on allcause and cardiovascular mortality.Nephrol Dial Transplant,2003,18:1731-1740.
6Chen NX,O’Neill KD,Duan D,et al.Phosphorus and ure mic serum up-regulate osteopontin expression in vascular smooth muscle cells.Kidney Int,2002,62:1724-1731.
7Proudfoot D,Skepper JN,Hegyi L,et al.The role of apoptosis in the initi-ation of vascular calcification.Z Kardiol,2001,90:S43-S46.
8Blockga L,Klassenps M,Lazarusjm A,et al.Mineralmetabolism,mortali-ty,and morbidity in maintenance hemodialysis.J Am Soc Nephrol,2004,15:2208-2218.
9Giachelhcm H.Vascular calcification mechanisms.J Am Soc Nephrol,2004,15:2959-2964.
10Hamanoat S,Osetoas J,Fujiin M,et al.Impact of lowering dialysate cal-cium concentration on serum bone turnover markers in hemodialysis patients.Bone,2005,36:909-916.
2Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med, 2000, 342 : 1478-1483.
3Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis:a cross-sectional study. Lancet,2003, 361 (9360) : 827-833.
4US Renal Data System (USRDS):1999 Annual Data Report.Bethesda, National Institute of Diabetes and Kidney Diseases,1999.
5Yokoyama K. Evaluation of coronary artery calcification in ESRD patients. Clin Calcium, 2004, 14:109-115.
6Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium ×phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis, 1998, 31:607-617.
7Levin NW, Hoenich NA. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr Opin Nephrol Hypertens, 2001, 10:563 -568.
8Giachelli CM, Jono S, Shioi A, et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis, 2001, 38 (4 Suppl 1 ) : S34-S37.
9Price PA, Lira JE. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem, 2003, 278 : 22144-22152.
10Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest, 2003,112 : 357-366.
6Suzanne Watnick,Susan T. Crowley.ESRD Care Within the US Department of Veterans Affairs: A Forward-Looking Program With an Illuminating Past[J]. American Journal of Kidney Diseases . 2013
7Kim Y,Evange LS.Development and Cultural Adaptation Of the Spanish Version of the End Stage Renal Disease Adherence Questionnaire (SESRD-AQ). Nephrol Nurs J . 2013
8Muzaale AD,Massie AB,Wang MC,et al.Risk of end-stage renal disease following live kidney donation. The Journal of The American Medical Association . 2014
9Abdelwahab HH,Shigidi MM,Ibrahim LS,et al.Barriers to kidney transplantation among adult Sudanese patients on maintenance hemodialysis in dialysis units in Khartoum State. Saudi J Kidney Dis Transpl . 2013
10Vujicic B,Mikolasevic I,Racki S,et al.BCM-body composition monitor:a new tool for the assessment of volume-dependent hypertension in patients on maintenance haemodialysis. Collegium Antropologicum . 2013
